Back to top

Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street

Lake Street analyst Chad Messer maintained a Buy rating on Coya Therapeutics, Inc. today and set a price target of $16.00. The company’s shares clo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coya Therapeutics, Inc. (COYA)